Frequent contributor Dave McGlasson and I assisted with this January 11 Advance for Administrators of the Laboratory Karen Appold article entitled New Antiplatelet Drugs Bring Benefits. You may find the discussion helpful. The article requires one minor edit when reading, the glycoprotein IIb/IIIa inhibitors are described as “injectable,” they are actually administered intravenously. I hope you enjoy the article. Geo.
Feb 2 2012
Comments (0)Antiplatelet Therapy
No comments here.